VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

Clinical trial NCT00063713 · COMPLETED

Trial details

NCT number: NCT00063713
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2003-06-01
Primary completion: 2005-12-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.